BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25439451)

  • 41. Impact of blood transfusions on short- and long-term mortality in patients who underwent transcatheter aortic valve implantation.
    Escárcega RO; Lipinski MJ; Magalhaes MA; Baker NC; Minha S; Okubagzi PG; Torguson R; Chen F; Ben-Dor I; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2015 Jan; 115(1):93-9. PubMed ID: 25491008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2012 Feb; 5(2):207-14. PubMed ID: 22361606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
    Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation.
    Seidler T; Hünlich M; Puls M; Hasenfuß G; Jacobshagen C
    Clin Res Cardiol; 2017 Mar; 106(3):183-191. PubMed ID: 27687044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement.
    Barbanti M; Binder RK; Freeman M; Wood DA; Leipsic J; Cheung A; Ye J; Tan J; Toggweiler S; Yang TH; Dvir D; Maryniak K; Lauck S; Webb JG
    EuroIntervention; 2013 Dec; 9(8):929-35. PubMed ID: 24035884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study.
    D'Errigo P; Barbanti M; Ranucci M; Onorati F; Covello RD; Rosato S; Tamburino C; Santini F; Santoro G; Seccareccia F;
    Int J Cardiol; 2013 Sep; 167(5):1945-52. PubMed ID: 22633667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis.
    Hayashida K; Morice MC; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Lefèvre T
    J Am Coll Cardiol; 2012 Feb; 59(6):566-71. PubMed ID: 22300690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry.
    Onorati F; D'Errigo P; Barbanti M; Rosato S; Covello RD; Maraschini A; Ranucci M; Santoro G; Tamburino C; Grossi C; Santini F; Menicanti L; Seccareccia F;
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1529-39. PubMed ID: 23856202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cut-down outperforms complete percutaneous transcatheter valve implantation.
    Mach M; Wilbring M; Winkler B; Alexiou K; Kappert U; Delle-Karth G; Grabenwöger M; Matschke K
    Asian Cardiovasc Thorac Ann; 2018 Feb; 26(2):107-113. PubMed ID: 29411636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 7-Year Single-Center Experience of Transfemoral TAVI: Evolution of Surgical Activity and Impact on Vascular Outcome.
    Lareyre F; Raffort J; Dommerc C; Habib Y; Bourlon F; Mialhe C
    Angiology; 2018 Jul; 69(6):532-539. PubMed ID: 29105493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial).
    McCabe JM; Huang PH; Cohen DJ; Blackstone EH; Welt FGP; Davidson MJ; Kaneko T; Eng MH; Allen KB; Xu K; Lowry AM; Lei Y; Rajeswaran J; Brown DL; Mack MJ; Webb JG; Smith CR; Leon MB; Eisenhauer AC;
    Am J Cardiol; 2016 May; 117(10):1643-1650. PubMed ID: 27036077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transradial
    Radhakrishnan SL; Ho KK
    World J Cardiol; 2020 Nov; 12(11):571-583. PubMed ID: 33312442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of CMS coverage decision on access to transcatheter aortic valve replacement.
    O'Neill BP; O'Neill WW; Williams D; Cohen MG; Heldman AW; Macon C; Martinez CA; Alfonso CE; Clark PM; Velasquez O; Seo D; Clermont PG; Moscucci M
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):114-21. PubMed ID: 24436032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in outcome after transfemoral transcatheter aortic valve implantation.
    Van Mieghem NM; Chieffo A; Dumonteil N; Tchetche D; van der Boon RM; Buchanan GL; Marcheix B; Vahdat O; Serruys PW; Fajadet J; Carrié D; Colombo A; de Jaegere PP
    Am Heart J; 2013 Feb; 165(2):183-92. PubMed ID: 23351821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The transradial approach during transcatheter structural heart disease interventions: a review.
    Allende R; Ribeiro HB; Puri R; Urena M; Abdul-Jawad O; del Trigo M; Veiga G; Ortas Mdel R; Paradis JM; De Larochellière R; Rodés-Cabau J
    Eur J Clin Invest; 2015 Feb; 45(2):215-25. PubMed ID: 25556629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab.
    Philippe F; Larrazet F; Meziane T; Dibie A
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):67-73. PubMed ID: 14696162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transradial Crossover Balloon Occlusion Technique for Primary Access Hemostasis During Transcatheter Aortic Valve Replacement: Initial Experience With the Oceanus 140 cm and 200 cm Balloon Catheters.
    Junquera L; Vilalta V; Trillo R; Sabaté M; Latib A; Nombela-Franco L; Moris C; Garcia Del Blanco B; Larman M; Hernandez JM; Iñiguez A; Amat-Santos I; Fernandez-Nofrerias E; Regueiro A; Colombo A; Tzanis G; Jiménez-Quevedo P; Pérez-Serranos I; Duran-Priu M; Duocastella L; Paradis JM; Rodés Cabau J
    J Invasive Cardiol; 2020 Aug; 32(8):283-288. PubMed ID: 32737263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postoperative delirium following transcatheter aortic valve implantation: a historical cohort study.
    Tse L; Bowering JB; Schwarz SK; Moore RL; Burns KD; Barr AM
    Can J Anaesth; 2015 Jan; 62(1):22-30. PubMed ID: 25337965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety.
    Johansson M; Nozohoor S; Kimblad PO; Harnek J; Olivecrona GK; Sjögren J
    Ann Thorac Surg; 2011 Jan; 91(1):57-63. PubMed ID: 21172486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.